SMB·BIO

Enex to pursue 'K-lifestyle' business with Chinese biotech partner

by
조 문술
Published : June 25, 2026 - 15:39:45
    • Copy Completed!

View Korean Original

Signs strategic MOU with China's Imei Biotechnology; eyes expansion into beauty and medical sectors

The Enex 3.0 Steering Committee launches Thursday at Enex headquarters in Seocho-dong, Seoul. Enex CEO Park Jin-gyu (fifth from left), Lin Yingyun, CEO of China's Imei Biotechnology, Dermato Bio CEO Ahn Seong-gwan, and Li Xuanzhen, marketing director of Imei's medical aesthetics business, sign a partnership agreement to mark the committee's launch. [Enex]
The Enex 3.0 Steering Committee launches Thursday at Enex headquarters in Seocho-dong, Seoul. Enex CEO Park Jin-gyu (fifth from left), Lin Yingyun, CEO of China's Imei Biotechnology, Dermato Bio CEO Ahn Seong-gwan, and Li Xuanzhen, marketing director of Imei's medical aesthetics business, sign a partnership agreement to mark the committee's launch. [Enex]

Space solutions company Enex said Thursday it will launch a new "K-lifestyle" business initiative.

The company signed a strategic MOU with China's Imei Biotechnology, which operates beauty and medical businesses in Shenzhen.

Under the agreement, the two companies will pursue beauty and wellness space projects in China, develop K-lifestyle space solutions, identify local strategic partners and build a joint brand. Enex will provide space planning, interior design and customized furniture solutions, while Imei will handle local business development, partner sourcing, marketing and commercialization.

Following the signing, the two sides plan to form a joint task force to identify pilot projects in China and move toward commercialization, with a stated goal of generating tangible business results.

Beyond its core space solutions business, Enex intends to develop beauty and medical ventures as new growth engines. The Enex 3.0 Steering Committee, launched Thursday, is dedicated to securing future growth drivers and expanding the company's global business. Park and Ahn will co-chair the committee.

Enex made a strategic equity investment of 2 billion won ($1.3 million) in Dermato Bio on June 9, acquiring a 6.67 percent stake through a third-party rights offering.

"We will strengthen the competitiveness of our existing business in response to the rapidly changing industrial environment and consumer trends," the company said. "At the same time, we will actively pursue new growth businesses and expand into global markets."

Co-chairman Ahn said the Enex 3.0 initiative "is not simply an announcement of new businesses, but a growth project centered on execution and results," adding that the committee aims to "create real business opportunities with domestic and international partners and build a foundation for future growth."


freiheit@heraldcorp.com
This content was produced with the assistance of AI translation services.

MOST READ